Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Grwth 3 Regulatory News (MIG3)

Share Price Information for Maven Grwth 3 (MIG3)

Share Price is delayed by 15 minutes
Get Live Data
43.80    0.00 (0.00%)
Bid:
42.80
Ask:
44.80
Spread: 2.00 (4.673%)
Market Cap: £68.37m
MIG3 Live PriceLast checked at - London Stock Exchange

Intraday Maven Grwth 3 Share Chart

Interim Management Statement

17 Oct 2008 14:14

RNS Number : 1250G
Aberdeen Growth Opps VCT PLC
17 October 2008
 



Aberdeen Growth Opportunities VCT PLC 

Interim Management Statement 

1. Net Asset Value

Ordinary share net asset value (NAV) of 90.65p at 31 August 2008 (97.8p at 31 May 2008)

C Ordinary share net asset value (NAV) of 97.6p at 31 August 2008 (99.2p at 31 May 2008)

The NAVs shown above are unaudited and reflect the closing bid prices of quoted securities at 31 August 2008. Unlisted companies are normally valued on a six-monthly basis and the NAVs include the Directors' valuations of unlisted investments as at 31 May 2008 adjusted for material developments within the portfolios since that date.  

2. Investments and disposals

For the Ordinary share portfolio, during the quarter ended 31 August 2008, investments totalling £498,000 were made in six unlisted or AIM/PLUS quoted companies. During the same period, a combination of partial and complete disposals of five unlisted or AIM quoted investments generated aggregate proceeds of £486,400 against cost of £309,138.

For the C share portfolio, during the quarter ended 31 August 2008, investments totalling £698,000 were made in four unlisted or AIM/PLUS quoted companies. During the same period, a combination of partial and complete disposals of four unlisted or AIM quoted investments generated aggregate proceeds of £620,246 against cost of £380,289.

There were no other material transactions during the period under review. 

3. Recent developments 

No further investments have been made since 31 August 2008.

Since that date, a partial disposal of one investment from the Ordinary share portfolio generated proceeds of £1,516,000 against cost of £884,000 and a partial disposal of one investment from the C share portfolio, generated proceeds of £2,329,000 against cost of £1,359,000.

Being invested mainly in unlisted companies, the portfolio is to some degree protected from the current volatility of stock markets. However, the recent, dramatic fall in the value of stocks quoted on AIM has reduced the NAV of the Ordinary Shares by 8p and that of the C Shares by 5p as at close of business on 16 October. The Board is not aware of any other events or transactions that have taken place between 31 August 2008 and the date of publication of this statement that have had a material impact on the financial position of the Company.

Issued on behalf of the Board

Aberdeen Asset Management PLC, Secretary

17 October 2008

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGUGUGUUPRGWM
Date   Source Headline
27th Mar 20251:06 pmRNSIssue of Equity
27th Mar 202510:25 amRNSUpdate re: Offers for Subscription
24th Mar 20253:53 pmRNSUnaudited Net Asset Value
18th Mar 20253:37 pmRNSAnnual Financial Report
28th Feb 20254:32 pmRNSTransaction in Own Shares
27th Feb 20251:54 pmRNSUnaudited NAV and Proposed Final Dividend
19th Feb 202510:17 amRNSDirector/PDMR Shareholding
19th Feb 202510:14 amRNSDirector/PDMR Shareholding
19th Feb 202510:06 amRNSIssue of Equity
28th Jan 202512:15 pmRNSStatement re Offer for Subscription
18th Dec 20249:35 amRNSIssue of Equity
13th Dec 20242:42 pmRNSNet Asset Value(s)
14th Nov 20242:55 pmRNSResult of General Meeting
25th Oct 20243:49 pmRNSTransaction in Own Shares
27th Sep 20244:31 pmRNSPublication of a Prospectus
6th Sep 202410:25 amRNSDirector/PDMR Shareholding
6th Sep 202410:01 amRNSIssue of Equity
5th Sep 20242:26 pmRNSStatement re Dividend Investment Scheme
5th Sep 20241:40 pmRNSUnaudited Net Asset Value
18th Jul 20245:27 pmRNSHalf-year Report
10th Jul 20245:08 pmRNSTransaction in Own Shares
8th Jul 20244:07 pmRNSStatement re NAV and Interim Dividend
18th Jun 202411:53 amRNSStatement re Intended Offers for Subscription
10th May 20244:11 pmRNSTransaction in Own Shares
3rd May 20249:35 amRNSDirector/PDMR Shareholding
3rd May 20249:33 amRNSIssue of Equity
2nd May 20241:31 pmRNSResult of AGM
1st May 202410:06 amRNSDirector/PDMR Shareholding
1st May 202410:03 amRNSIssue of Equity
26th Apr 20242:40 pmRNSNet Asset Value - Dividend Investment Scheme
19th Apr 202412:17 pmRNSIssue of Supplementary Prospectus
5th Apr 20243:37 pmRNSIssue of Equity
28th Mar 202410:16 amRNSStatement re Offer for Subscription
27th Mar 202410:36 amRNSIssue of Equity
22nd Mar 202410:14 amRNSIssue of Supplementary Prospectus
20th Mar 20243:46 pmRNSUnaudited Net Asset Value
15th Mar 20245:18 pmRNSAnnual Financial Report
21st Feb 20244:24 pmRNSTransaction in Own Shares
8th Feb 202410:30 amRNSDirector/PDMR Shareholding
8th Feb 202410:28 amRNSDirector/PDMR Shareholding
8th Feb 202410:15 amRNSIssue of Equity
6th Feb 202411:07 amRNSDividend Declaration
19th Dec 20233:25 pmRNSIssue of Equity
18th Dec 20235:17 pmRNSUnaudited Net Asset Value
5th Dec 202311:42 amRNSDirectorate Change
9th Nov 20233:47 pmRNSResult of General Meeting
8th Nov 20234:01 pmRNSTransaction in Own Shares
7th Nov 20234:47 pmRNSTransaction in Own Shares
19th Oct 20234:15 pmRNSNet Asset Value
13th Oct 20234:56 pmRNSPublication of a Prospectus

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.